Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Potential benefit of higher dose daunorubicin in patients harbouring a FLT3-ITD mutation: Updated results of the AML17 trial

Russell, N. H., Hills, Robert Kerrin, Kell, J., Cavenagh, J., Kjeldsen, L., McMullin, M. F., Cahalin, P., Dennis, M., Friis, L., Grech, A., Milligan, D., Clark, R. and Burnett, A. K. 2016. Potential benefit of higher dose daunorubicin in patients harbouring a FLT3-ITD mutation: Updated results of the AML17 trial. British Journal of Haematology 173 (S1) , p. 9.

Full text not available from this repository.
Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Additional Information: Special Issue: Abstracts of the XXXVI World Congress of the International Society of Hematology Hosted by the British Society for Haematology, 18–21 April 2016, Glasgow, UK
Publisher: Wiley-Blackwell
ISSN: 0007-1048
Last Modified: 08 Jul 2019 12:44
URI: http://orca-mwe.cf.ac.uk/id/eprint/98413

Actions (repository staff only)

Edit Item Edit Item